病毒感染GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.
期刊:PloS one发表年份:2017作者:Michaël Esquerré; Myriam Bouillette-Marussig; Anne Goubier; Marie Momot; Christophe Gonindard; Hélène Keller; Astrid Navarro; Marie-Christine Bissery
